| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,523,000 | 2,609,000 | 2,629,000 | 2,662,000 | | Cost of Revenue |
-
| (1,578,000) | 1,578,000 | 7,207,000 | | | Gross Profit |
-
| 4,187,000 | 1,051,000 | (4,545,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 161,000 | 3,900,000 | 720,000 | (4,644,000) | | Non Recurring |
-
| 315,000 |
-
|
-
| | Others | 2,146,000 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 216,000 | (28,000) | 331,000 | 99,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,000 | (27,000) | (9,000) | 27,000 | | Earnings Before Interest And Taxes | 240,000 | (55,000) | 322,000 | 126,000 | | Interest Expense | 59,000 | 65,000 | 56,000 | 55,000 | | Income Before Tax | 181,000 | (120,000) | 266,000 | 71,000 | | Income Tax Expense | (40,000) | 47,000 | 82,000 | (5,000) | | Minority Interest | (4,000) | (9,000) |
-
| (3,000) | | | | Net Income From Continuing Ops | 230,000 | (176,000) | 184,000 | 73,000 | | | Non-recurring Events | | Discontinued Operations | 4,000 | (21,000) | (4,000) | 7,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 221,000 | (197,000) | 180,000 | 80,000 | | Preferred Stock And Other Adjustments |
-
| 4,000 | (4,000) |
-
| | | Net Income Applicable To Common Shares | $221,000 | ($193,000) | $176,000 | $80,000 |
|
0.37% Nasdaq 
Income Statement
